Ying Xia

Matthew M. Piaseczny^*,1,2, 

Graciella M. Pio^*,1,2, 

Jenny E. Chu^1,2, 

Ying Xia¹, 

Kim Nguyen^1,3, 

David Goodale¹, 

Alison Allan^1,2,4,5 

¹London Regional Cancer Program, London Health Sciences Centre, 

²Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, Western University, 

³Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University, 

⁴Department of Oncology, Schulich School of Medicine & Dentistry, Western University, 

⁵, Lawson Health Research Institute 

Aizhu Lu^1,2, 

Jerry Wang^1,2, 

Ying Xia^1,2, 

Ruonan Gu¹, 

Kyoung-Han Kim^1,2, 

Erin E. Mulvihill^1,3, 

Darryl R. Davis^1,2, 

Rob S. Beanlands¹, 

Wenbin Liang^1,2 

¹, University of Ottawa Heart Institute, 

²Department of Cellular and Molecular Medicine, University of Ottawa, 

³Department of Biochemistry, Microbiology and Immunology, University of Ottawa 

Yifan Wu^1,2, 

Ying Xia¹, 

Lili Song^1,3, 

Xixi Wang^1,3, 

Jun Zhang^1,2, 

Jing Liu³, 

Zhihong Wang^3,4 

¹College of Life Sciences, Tiangong University, 

², Tiangong Huikang Medical Technology (Tianjin) Company, 

³Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, 

⁴Institute of Transplant Medicine, School of Medicine, Key Laboratory of Bioactive Materials of Ministry of Education, Nankai University